IRWD - Ironwood Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IRWD is currently covered by 2 analysts with an average price target of $3.6. This is a potential upside of $2.1 (140%) from yesterday's end of day stock price of $1.5.

Ironwood Pharmaceuticals's activity chart (see below) currently has 99 price targets and 82 ratings on display. The stock rating distribution of IRWD is 50% BUY and 50% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 73.76% with an average time for these price targets to be met of 219 days.

Highest price target for IRWD is $1, Lowest price target is $1, average price target is $1.

Most recent stock forecast was given by MOHIT BANSAL from WELLS FARGO on 14-Apr-2025. First documented stock forecast 10-Dec-2015.

Currently out of the existing stock ratings of IRWD, 3 are a BUY (50%), 3 are a HOLD (50%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$1

$-0.66 (-39.76%)

$7

6 months 17 days ago
(14-Apr-2025)

1/4 (25%)

$0.28 (38.89%)

120

Buy

$21

$19.34 (1165.06%)

$19

1 years 8 months 16 days ago
(15-Feb-2024)

0/3 (0%)

$6.42 (44.03%)

Buy

$15

$13.34 (803.61%)

$15

3 years 1 months 30 days ago
(01-Sep-2022)

9/10 (90%)

$4.12 (37.87%)

630

Hold

$13

$11.34 (683.13%)

3 years 2 months 16 days ago
(15-Aug-2022)

1/2 (50%)

$0.99 (8.24%)

524

$14

$12.34 (743.37%)

4 years 20 days ago
(11-Oct-2021)

4/4 (100%)

$0.15 (1.08%)

259

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IRWD (Ironwood Pharmaceuticals) average time for price targets to be met?

On average it took 219 days on average for the stock forecasts to be realized with a an average price target met ratio 73.76

Which analyst has the current highest performing score on IRWD (Ironwood Pharmaceuticals) with a proven track record?

TIMOTHY CHIANG

Which analyst has the most public recommendations on IRWD (Ironwood Pharmaceuticals)?

Timothy Chiang works at CAPITAL ONE and has 4 price targets and 4 ratings on IRWD

Which analyst is the currently most bullish on IRWD (Ironwood Pharmaceuticals)?

David Amsellem with highest potential upside - $19.34

Which analyst is the currently most reserved on IRWD (Ironwood Pharmaceuticals)?

Mohit Bansal with lowest potential downside - -$0.66

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?